Checkpoint Capital

Latest statistics and disclosures from Checkpoint Capital's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ARGX, RYTM, CORT, IRON, RVMD, and represent 91.05% of Checkpoint Capital's stock portfolio.
  • Added to shares of these 7 stocks: IRON (+$11M), CRNX (+$11M), RVMD (+$9.9M), STOK, CORT, CYTK, ARGX.
  • Started 3 new stock positions in STOK, CYTK, CRNX.
  • Reduced shares in these 4 stocks: RYTM (-$30M), SEPN (-$5.7M), PTGX, KYMR.
  • Sold out of its position in PTGX.
  • Checkpoint Capital was a net buyer of stock by $54k.
  • Checkpoint Capital has $299M in assets under management (AUM), dropping by 39.09%.
  • Central Index Key (CIK): 0001977548

Tip: Access up to 7 years of quarterly data

Positions held by Checkpoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Checkpoint Capital

Checkpoint Capital holds 10 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Argenx Se Sponsored Adr (ARGX) 37.1 $111M 150k 737.56
 View chart
Rhythm Pharmaceuticals (RYTM) 25.8 $77M -27% 764k 100.99
 View chart
Corcept Therapeutics Incorporated (CORT) 10.9 $33M +14% 392k 83.11
 View chart
Disc Medicine (IRON) 9.5 $28M +62% 430k 66.08
 View chart
Revolution Medicines (RVMD) 7.7 $23M +75% 492k 46.70
 View chart
Crinetics Pharmaceuticals In (CRNX) 3.6 $11M NEW 260k 41.65
 View chart
Septerna (SEPN) 1.8 $5.3M -51% 283k 18.81
 View chart
Stoke Therapeutics (STOK) 1.7 $5.0M NEW 212k 23.50
 View chart
Kymera Therapeutics (KYMR) 1.2 $3.5M -42% 62k 56.60
 View chart
Cytokinetics Com New (CYTK) 0.7 $2.1M NEW 38k 54.96
 View chart

Past Filings by Checkpoint Capital

SEC 13F filings are viewable for Checkpoint Capital going back to 2023